In this segment of the July 2021 interview, Dave Asprey and Dr. Dale Bredesen discuss a bold vision for the 21st century: turning chronic, complex neurological diseases such as Alzheimer’s, Parkinson’s, and multiple sclerosis into rare conditions through a systems‑based, personalized approach. They contrast the 20th‑century model of treating acute infections with a new paradigm that looks beyond single‑target drugs to understand the underlying network dysfunctions. Dr. Bredesen shares a personal case of toxin‑induced brain injury that healed after following the ReCODE protocol, emphasizing that brain tissue can regenerate. The conversation highlights a suite of objective biomarkers—EEG measures (P300, dominant alpha rhythm, theta‑beta ratio), PET and MRI imaging, volumetric analyses, and cognitive assessments (MOCA, MMSE, CNS Vital Signs)—that demonstrate quantifiable improvements in patients undergoing the program. The speakers also note the growing acceptance of the protocol, moving from skepticism to clinical legitimacy, and hint at future therapies such as stem‑cell interventions for traumatic brain injury.
Chapters
Bulletproof radio, a state of high performance.
It's one of those things, though, if you only get 99% coverage, I think you can consider it just one of the great achievements of really the century. Because dementia has been an issue for a very long time, and it's just a much bigger issue in the second half of the last century. And it's getting worse and worse now. And so the demand for what do I do to prevent it is actually big enough that we all know someone who doesn't recognize you anymore. No one wants to go there.
Great point. And so here's my prediction, Dave. Last century we conquered acute illness, tb, and even toward the end of the century, even HIV is much better, much less of a problem than it was, of course. TB, diphtheria, pneumococcal pneumonia. We conquered those. The 21st century will see, I believe, the end, essentially making very rare all of these complex chronic illnesses. Alzheimer's, Parkinson's, psp, just go right down the list. Lupus, rheumatoid arthritis, all of these things because they are fundamentally different than 20th century diseases. And people kept trying to do the same thing. We're just going to throw another medicine at them, but. But now things are changing and we're able to see what these things actually represent. We're able to look outside Flatland and see what's actually going on. And so we will be able, I think, to make all of these rare diseases now. Yeah, you'll occasionally, as you said, there are going to be people who hit their head enough. You may see some of these. Although even there, there will be options like stem cells and things.
You can grow it back. I hit my head hard. I had documented toxin induced brain damage from toxin mold that Daniel Amen found. It's not there anymore. It does grow back. You can grow it back. I just didn't have a program like yours to do it. I had spent a huge amount of money and tried everything on the planet because I was desperate. So the fact that you've systematized it and legitimized it so people don't. Don't say that someone on the Recode program is crazy. Whereas most people say, dave, what you did was crazy. I'm like, yeah, but 20 years later, look at me.
Yeah, yeah. Crazy like Fox. Yeah, when it works. So the bottom line is we're seeing improvements in electrophysiological parameters. You can look at things like P300. You can look at things like dominant alpha rhythm, theta beta ratio, improvement in PET scans. You can look at changes there Improvements in mri, volumetrics, improvements in MOCA scores, mmse, cns, vital signs, brain hq. I mean, just right down the list. So this is not someone seems like they're better. They are showing quantifiable objective improvements.
